Compare · GPOR vs IRMD
GPOR vs IRMD
Side-by-side comparison of Gulfport Energy Corporation (GPOR) and iRadimed Corporation (IRMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- GPOR operates in Energy, while IRMD operates in Health Care - the two are in different parts of the market.
- GPOR is the larger of the two at $1.33B, about 1.1x IRMD ($1.21B).
- Over the past year, GPOR is down 11.2% and IRMD is up 55.6% - IRMD leads by 66.8 points.
- GPOR has been more active in the news (13 items in the past 4 weeks vs 5 for IRMD).
- GPOR has more recent analyst coverage (25 ratings vs 1 for IRMD).
- Company
- Gulfport Energy Corporation
- iRadimed Corporation
- Price
- $167.17-0.65%
- $94.37+0.32%
- Market cap
- $1.33B
- $1.21B
- 1M return
- -6.52%
- +8.62%
- 1Y return
- -11.23%
- +55.61%
- Industry
- Oil & Gas Production
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2014
- News (4w)
- 13
- 5
- Recent ratings
- 25
- 1
Gulfport Energy Corporation
Gulfport Energy Corporation engages in the exploration, development, acquisition, and production of natural gas, crude oil, and natural gas liquids (NGL) in the United States. Its principal properties include Utica Shale covering an area of approximately 193,000 net reservoir acres primarily located in Eastern Ohio; and SCOOP covering an area of approximately 73,000 net reservoir acres primarily located in Oklahoma. As of December 31, 2020, it had 2.6 trillion cubic feet of natural gas equivalent of proved reserves; and proved undeveloped reserves of 7 MMbbl of oil, 923 Bcf of natural gas, and 16 MMbbl of NGL. The company was incorporated in 1997 and is headquartered in Oklahoma City, Oklahoma.
iRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Latest GPOR
- Director Silver Point Capital L.P. was granted 1,028 shares (SEC Form 4)
- Director Reganato David A was granted 1,028 shares (SEC Form 4)
- SVP of Reservoir Engineering Sluiter Michael was granted 1,307 shares, increasing direct ownership by 14% to 10,338 units (SEC Form 4)
- President & CEO Dell'Osso Domenic J Jr was granted 22,749 shares (SEC Form 4)
- Director Cutt Timothy J. was granted 1,028 shares, increasing direct ownership by 4% to 29,513 units (SEC Form 4)
- Director Martinez Jason Joseph was granted 1,028 shares, increasing direct ownership by 26% to 4,916 units (SEC Form 4)
- Director Powers Jean Marie was granted 1,028 shares, increasing direct ownership by 33% to 4,129 units (SEC Form 4)
- Director Shafer-Malicki Mary was granted 1,028 shares, increasing direct ownership by 33% to 4,164 units (SEC Form 4)
- Director Wolf David D was granted 1,028 shares, increasing direct ownership by 23% to 5,490 units (SEC Form 4)
- SEC Form 3 filed by new insider Dell'Osso Domenic J Jr
Latest IRMD
- Director Scharen-Guivel Hilda Frederique sold $285,000 worth of shares (3,000 units at $95.00), decreasing direct ownership by 35% to 5,598 units (SEC Form 4)
- CEO, President, Chairman Susi Roger E. sold $226,507 worth of shares (2,500 units at $90.60) as part of a pre-agreed trading plan (SEC Form 4)
- CEO, President, Chairman Susi Roger E. sold $691,044 worth of shares (7,500 units at $92.14) as part of a pre-agreed trading plan (SEC Form 4)
- CEO, President, Chairman Susi Roger E. sold $657,265 worth of shares (7,500 units at $87.64) as part of a pre-agreed trading plan (SEC Form 4)
- IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by iRadimed Corporation
- CEO, President, Chairman Susi Roger E. sold $631,341 worth of shares (7,500 units at $84.18) as part of a pre-agreed trading plan (SEC Form 4)
- CEO, President, Chairman Susi Roger E. sold $642,862 worth of shares (7,500 units at $85.71) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by iRadimed Corporation
- iRadimed Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits